Alice Loo
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Cancer Research and Treatments, Advanced Breast Cancer Therapies, Melanoma and MAPK Pathways, Protein Tyrosine Phosphatases
Most-Cited Works
- → The landscape of somatic copy-number alteration across human cancers(2010)4,082 cited
- → High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response(2015)1,424 cited
- → Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening(2017)693 cited
- → The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1(2017)581 cited
- → PTEN-deficient cancers depend on PIK3CB(2008)549 cited
- → Single-vector inducible lentiviral RNAi system for oncology target validation(2009)454 cited
- → PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers(2009)453 cited
- → Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1(2018)436 cited
- → The aging olfactory epithelium: Neurogenesis, response to damage, and odorant‐induced activity(1996)164 cited
- → Dynamics of β-Amyloid Reductions in Brain, Cerebrospinal Fluid, and Plasma of β-Amyloid Precursor Protein Transgenic Mice Treated with a γ-Secretase Inhibitor(2005)159 cited